Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry

Title:	Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry
Authors:	Sebastiani, Marco^{Aff1, IDs10067021057343_cor1}; Venerito, Vincenzo^Aff2; Bugatti, Serena^Aff3; Bazzani, Chiara^Aff4; Biggioggero, Martina^Aff5; Petricca, Luca^Aff6; Foti, Rosario^Aff7; Bortoluzzi, Alessandra^Aff8; Balduzzi, Silvia^Aff3; Visalli, Elisa^Aff7; Frediani, Bruno^Aff9; Manfredi, Andreina^Aff1; Gremese, Elisa^Aff6; Favalli, Ennio^Aff5; Iannone, Florenzo^Aff2; Ferraccioli, Gianfranco^Aff6; Lapadula, Giovanni^Aff2; Galli, Elena; Cantatore, Francesco Paolo; Lomater, Claudia; Atzeni, Fabiola; Gorla, Roberto; Fusaro, Enrico; Salaffi, Fausto; Conti, Fabrizio; Cauli, Alberto; Sarzi-Puttini, Piercarlo; Carletto, Antonio; Lopalco, Giuseppe
Source:	Clinical Rheumatology: Journal of the International League of Associations for Rheumatology. :1-9
Database:	Springer Nature Journals